-
Phase 2b Duchenne Muscular Dystrophy Trial Now Enrolling Boys Ages 4-6
A Phase 2b trial of the investigational therapy vamorolone has begun to enroll 4-to-6-year-old boys with Duchenne Muscular Dystrophy. Click here to learn more about this trial.
Are you interested in following this trial as it progresses?
Sorry, there were no replies found.
Log in to reply.